Teva Pharmaceutical Industries (TEVA) Net Income towards Common Stockholders Growth (5y) (2014 - 2026)
Powered by 
Analysis
Teva Pharmaceutical Industries (TEVA) Net Income towards Common Stockholders Growth (5y) (2014 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.56 Bn | 38.90 Bn | 2.15 Bn |
| 2 | Viatris | 19.13 Bn | 18.24 Bn | 1.46 Bn |
| 3 | Dr Reddys Laboratories | 9.86 Bn | 9.69 Bn | 396.53 Mn |
| 4 | Amneal Pharmaceuticals | 5.46 Bn | 5.33 Bn | 334.51 Mn |
| 5 | Bausch Health Companies | 2.37 Bn | 528.25 Mn | 2.10 Bn |
| 6 | Alvotech | 1.51 Bn | 1.37 Bn | 2.56 Mn |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn |
| 8 | Amphastar Pharmaceuticals | 992.90 Mn | 702.78 Mn | 93.47 Mn |
| 9 | Fennec Pharmaceuticals | 411.43 Mn | 370.18 Mn | 17.15 Mn |
| 10 | RedHill Biopharma | 181.39 Mn | 181.39 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -36.52% |
| Mar 31, 2026 | 35.17% |
| Dec 31, 2025 | 25.66% |
| Sep 30, 2025 | 15.99% |
| Jun 30, 2025 | 14.95% |
| Mar 31, 2025 | 26.10% |
| Dec 31, 2024 | -35.10% |
| Sep 30, 2024 | -4.59% |
| Jun 30, 2024 | -4.92% |
| Mar 31, 2024 | 47.34% |
| Dec 31, 2023 | 16.64% |
| Sep 30, 2023 | 17.90% |
| Jun 30, 2023 | -30.35% |
| Mar 31, 2023 | -17.50% |
| Dec 31, 2022 | 35.12% |
| Sep 30, 2022 | -34.48% |
| Jun 30, 2022 | 45.97% |
| Mar 31, 2022 | -29.75% |
| Dec 31, 2021 | 31.99% |
| Sep 30, 2021 | -2.54% |